I

InDex Pharmaceuticals Holding AB
STO:FLERIE

Watchlist Manager
InDex Pharmaceuticals Holding AB
STO:FLERIE
Watchlist
Price: 40.99 SEK 1.25% Market Closed
Market Cap: 3.2B SEK

Intrinsic Value

The intrinsic value of one FLERIE stock under the Base Case scenario is 5.54 SEK. Compared to the current market price of 40.99 SEK, InDex Pharmaceuticals Holding AB is Overvalued by 86%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

FLERIE Intrinsic Value
5.54 SEK
Overvaluation 86%
Intrinsic Value
Price
I
Worst Case
Base Case
Best Case

Valuation History
InDex Pharmaceuticals Holding AB

FLERIE
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for FLERIE cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

InDex Pharmaceuticals Holding AB
STO:FLERIE
SE
Pharmaceuticals
Market Cap
3.2B SEK
IPO
Oct 11, 2016
SE
Pharmaceuticals
Market Cap
3.2B SEK
IPO
Oct 11, 2016
Price
krfalse
EPS
krfalse
InDex Pharmaceuticals Holding AB
Company Overview
Loading...
Contacts
Loading...
How do you feel about FLERIE?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about InDex Pharmaceuticals Holding AB
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
InDex Pharmaceuticals Holding AB

Current Assets 1B
Cash & Short-Term Investments 865.1m
Receivables 158.4m
Other Current Assets 1.2m
Non-Current Assets 3.2B
Long-Term Investments 100k
PP&E 1.2m
Other Non-Current Assets 3.2B
Efficiency

Free Cash Flow Analysis
InDex Pharmaceuticals Holding AB

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
InDex Pharmaceuticals Holding AB

Revenue
100k SEK
Cost of Revenue
-19.7m SEK
Gross Profit
-19.6m SEK
Operating Expenses
-86.5m SEK
Operating Income
-106.1m SEK
Other Expenses
-121.9m SEK
Net Income
-228m SEK
Fundamental Scores

FLERIE Profitability Score
Profitability Due Diligence

InDex Pharmaceuticals Holding AB's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

19/100
Profitability
Score

InDex Pharmaceuticals Holding AB's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

FLERIE Solvency Score
Solvency Due Diligence

InDex Pharmaceuticals Holding AB's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
87/100
Solvency
Score

InDex Pharmaceuticals Holding AB's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

FLERIE Price Targets Summary
InDex Pharmaceuticals Holding AB

Wall Street analysts forecast FLERIE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for FLERIE is 57.12 SEK with a low forecast of 44.44 SEK and a high forecast of 71.4 SEK.

Lowest
Price Target
44.44 SEK
8% Upside
Average
Price Target
57.12 SEK
39% Upside
Highest
Price Target
71.4 SEK
74% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

InDex Pharmaceuticals Holding AB
does not pay dividends
Shareholder Yield

Current shareholder yield for FLERIE is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

FLERIE Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one FLERIE stock?

The intrinsic value of one FLERIE stock under the Base Case scenario is 5.54 SEK.

Is FLERIE stock undervalued or overvalued?

Compared to the current market price of 40.99 SEK, InDex Pharmaceuticals Holding AB is Overvalued by 86%.

Back to Top